
Opinion|Videos|August 30, 2024
Positioning Intravenous and Subcutaneous Biologics
Author(s)Jennifer Seminerio, MD
Dr. Seminerio talks about how she positions intravenous and subcutaneous biologics and which patients benefit from each route of administration.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you position IV and subQ biologics in your treatment algorithms? Which patients are ideal for IV and which patients are ideal for subQ?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























